28,048 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by BDF Gestion

BDF Gestion acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 28,048 shares of the healthcare conglomerate’s stock, valued at approximately $14,284,000. UnitedHealth Group makes up 1.4% of BDF Gestion’s portfolio, making the stock its 9th biggest holding.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Argus Investors Counsel Inc. raised its holdings in UnitedHealth Group by 2.9% during the fourth quarter. Argus Investors Counsel Inc. now owns 1,662 shares of the healthcare conglomerate’s stock worth $875,000 after buying an additional 47 shares during the last quarter. Valley National Advisers Inc. boosted its stake in UnitedHealth Group by 9.4% during the 4th quarter. Valley National Advisers Inc. now owns 1,416 shares of the healthcare conglomerate’s stock valued at $745,000 after purchasing an additional 122 shares during the last quarter. Strategic Blueprint LLC lifted its holdings in shares of UnitedHealth Group by 0.8% in the fourth quarter. Strategic Blueprint LLC now owns 3,897 shares of the healthcare conglomerate’s stock valued at $2,052,000 after purchasing an additional 30 shares in the last quarter. International Assets Investment Management LLC grew its holdings in UnitedHealth Group by 1.9% during the fourth quarter. International Assets Investment Management LLC now owns 4,468 shares of the healthcare conglomerate’s stock worth $2,352,000 after buying an additional 85 shares in the last quarter. Finally, Confluence Wealth Services Inc. lifted its stake in UnitedHealth Group by 10.2% during the 4th quarter. Confluence Wealth Services Inc. now owns 4,552 shares of the healthcare conglomerate’s stock valued at $2,397,000 after acquiring an additional 422 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 1.3 %

Shares of UNH traded down $7.48 during trading hours on Friday, hitting $558.76. The company had a trading volume of 2,964,027 shares, compared to its average volume of 4,283,194. The firm has a market cap of $514.28 billion, a P/E ratio of 34.29, a P/E/G ratio of 1.58 and a beta of 0.59. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $591.54. The stock’s 50 day moving average price is $520.58 and its 200 day moving average price is $504.70. The company has a quick ratio of 0.85, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the business earned $6.14 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.50%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. UBS Group upped their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research note on Thursday, July 18th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Robert W. Baird boosted their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, July 23rd. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $614.17.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.